Brandon S. Smith
Chief Operating OfficerMr. Brandon S. Smith has been Chief Operating Officer at Prothena Corporation plc since October 1, 2021 and served as its Chief Business Officer since March 2, 2020 until October 1, 2021. Mr. Smith was responsible for leading Prothena’s business development initiatives, portfolio strategic planning and alliance management activities. He was Chief Operating Officer of Iconic Therapeutics, Inc. since August 2017 until March 2020. Mr. Smith served as Senior Vice President of Corporate Development and Strategy at Impax Laboratories, Inc. since April 6, 2016 until June 6, 2017 and served as its Senior Vice President of Impax Generics Division from January 20, 2016 to April 6, 2016. He has experience leading strategy and corporate development functions in public biopharmaceutical companies. Mr. Smith served as Senior Vice President of Corporate Development and Strategy at Impax Laboratories Inc. until January 20, 2016. Mr. Smith oversees strategic planning, business development and licensing, alliance management, deal integration and portfolio management for both generic and brand businesses. He joined Impax in June 2012 and has played an integral role in setting the strategic direction for the company. Prior to joining Impax, he served as Executive Director at Amgen. Mr. Smith also held several positions of increasing responsibility at Amgen, including the head of strategy for the company’s biosimilars business unit and the head of strategy and transaction analysis supporting a variety of M&A and licensing activities. He worked at the Boston Consulting Group as a project leader and Production Engineer at BASF in operations. Mr. Smith has a Bachelor of Science in Chemical Engineering from the University of Michigan and Master of Business Administration from the University of Texas at Austin McCombs Graduate School of Business.
Positions
- Company NameProthena Corporation plcStock CodePRTAPositionChief Operating OfficerColleagues
- GGGene G. KinneyPresident, CEO & Director
- DGDaniel G. WelchIndependent Chairman
- TBTran B. NguyenChief Financial Officer
- WMWagner M. ZagoChief Scientific Officer
- KLKarin L. WalkerChief Accounting Officer & Controller
- LGLars Gosta EkmanIndependent Chair Emeritus
- RTRichard T. CollierIndependent Director
- SMShane Martin CookeIndependent Director
